To provide further support to our hypothesis and to assess the protein levels of filaggrin, eosinophil MBP and total IgE in atopic subjects, patients with AD, AR and BA were divided into different groups based on their severity scores. This evidence concerns the gene FLG and breast angiosarcoma.